Thomas D. Schmittgen

Pharmaceutics & Pharmaceutical Chemistry, The Ohio State University

Affiliated withThe Ohio State University

Research Area

Biography

Thomas D. Schmittgen has not added Biography.
If you are Thomas D. Schmittgen and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 31	2014

Other Publications

Article	Year
Expression pattern of mouse homolog of prostate-specific membrane antigen (FOLH1) in the transgenic adenocarcinoma of the mouse prostate model. The Prostate\| PubMed ID: 12712410	2003
Inhibition of pre-mRNA splicing by cisplatin and platinum analogs. International journal of oncology\| PubMed ID: 12888918	2003
Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients. International journal of cancer. Journal international du cancer\| PubMed ID: 12949815	2003
A high-throughput method to monitor the expression of microRNA precursors. Nucleic acids research\| PubMed ID: 14985473	2004
Diverse gene expression pattern during 5-fluorouridine-induced apoptosis. International journal of oncology\| PubMed ID: 16010409	2005
Increased expression of microRNA-155 in Epstein-Barr virus transformed lymphoblastoid cell lines. Genes, chromosomes & cancer\| PubMed ID: 16175574	2006
Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic acids research\| PubMed ID: 16192569	2005
MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. The Journal of biological chemistry\| PubMed ID: 16675453	2006
Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology\| PubMed ID: 16762633	2006
Apoptosis induced by novel aldehyde calpain inhibitors in human tumor cell lines. International journal of oncology\| PubMed ID: 16865282	2006
Comparison of RNA assay methods used to normalize cDNA for quantitative real-time PCR. Analytical biochemistry\| PubMed ID: 16930526	2006
Expression profiling identifies microRNA signature in pancreatic cancer. International journal of cancer. Journal international du cancer\| PubMed ID: 17149698	2007
Dynamin 2 regulates riboflavin endocytosis in human placental trophoblasts. Molecular pharmacology\| PubMed ID: 17565002	2007
The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding. The Journal of biological chemistry\| PubMed ID: 17588946	2007
Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer cell\| PubMed ID: 17785203	2007
Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors. RNA (New York, N.Y.)\| PubMed ID: 18025253	2008
Computational analysis of biological functions and pathways collectively targeted by co-expressed microRNAs in cancer. BMC bioinformatics\| PubMed ID: 18047715	2007
MicroRNAs and cancer: profile, profile, profile. International journal of cancer. Journal international du cancer\| PubMed ID: 18098138	2008
Part B--microRNAs: microRNA methods. Methods (San Diego, Calif.)\| PubMed ID: 18158126	2008
Real-time PCR quantification of precursor and mature microRNA. Methods (San Diego, Calif.)\| PubMed ID: 18158130	2008
MicroRNAs modulate the chemosensitivity of tumor cells. Molecular cancer therapeutics\| PubMed ID: 18187804	2008
Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 18223217	2008
Benign metastasizing leiomyoma of the lung: clinicopathologic, immunohistochemical, and micro-RNA analyses. Diagnostic molecular pathology : the American journal of surgical pathology, part B\| PubMed ID: 18382364	2008
Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and hearts. Biochemical and biophysical research communications\| PubMed ID: 18387358	2008
Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia. Cancer research\| PubMed ID: 18451139	2008
Analyzing real-time PCR data by the comparative C(T) method. Nature protocols\| PubMed ID: 18546601	2008
Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer research\| PubMed ID: 18593903	2008
High-throughput real-time PCR. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 18695961	2008
Regulation of microRNA processing in development, differentiation and cancer. Journal of cellular and molecular medicine\| PubMed ID: 18752632	2008
Integrating the MicroRNome into the study of lung disease. American journal of respiratory and critical care medicine\| PubMed ID: 18787215	2009
Detection of microRNA expression in human peripheral blood microvesicles. PloS one\| PubMed ID: 19002258	2008
A methodology for the combined in situ analyses of the precursor and mature forms of microRNAs and correlation with their putative targets. Nature protocols\| PubMed ID: 19131963	2009
Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. Hepatology (Baltimore, Md.)\| PubMed ID: 19711427	2009
Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma. Pancreas\| PubMed ID: 19730150	2009
MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer research\| PubMed ID: 19773441	2009
miR-31: a master regulator of metastasis? Future oncology (London, England)\| PubMed ID: 20021205	2010
Strong inverse correlation between microRNA-125b and human papillomavirus DNA in productive infection. Diagnostic molecular pathology : the American journal of surgical pathology, part B\| PubMed ID: 20736742	2010
MicroRNAs are mediators of androgen action in prostate and muscle. PloS one\| PubMed ID: 21048966	2010
miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines. Biochemical and biophysical research communications\| PubMed ID: 21055388	2010
miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. Biochemical and biophysical research communications\| PubMed ID: 21329664	2011
MicroRNA replacement therapy for cancer. Pharmaceutical research\| PubMed ID: 21879389	2011
miR-221 silencing blocks hepatocellular carcinoma and promotes survival. Cancer research\| PubMed ID: 22009537	2011
Microbiomarkers with big impact in CLL. Blood\| PubMed ID: 24030253	2013
A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma. Annals of surgical oncology\| PubMed ID: 24046106	2014
Tumor suppressive function of mir-205 in breast cancer is linked to HMGB3 regulation. PloS one\| PubMed ID: 24098490	2013
Studies on the Antileishmanial Mechanism of Action of the Arylimidamide DB766: Azole Interactions and Role of CYP5122A1. Antimicrobial agents and chemotherapy\| PubMed ID: 24890590	2014